Atrial Fibrillation Progression Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 255 participants.
Also called NCT01570361
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 255 participants
- Sponsor
- Registry
-
NCT01570361
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Terminated
Technical summary
Registry record NCT01570361. Randomized; no masking; primary purpose treatment. Start 2012-02-13 (actual); primary completion 2018-12-19 (actual). Results posted on 2020-05-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrial Fibrillation Progression Trial
- Acronym
- ATTEST
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Catheter Ablation
- Intervention (Drug)
- Drug Treatment
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct01570361- Content hash
871683b78dfad9b78725233c06607e54fe0c604d7f4362fc554cf24c35e98ed6